Skye Bioscience SKYE
NASDAQ SKYE
$1.59 -0.03 (-1.74%)
As of: Oct 21, 2026 · 3:38 PM EDT

Skye Bioscience (SKYE) Non-Current Debt (2013 - 2021)

Updated

Skye Bioscience's Non-Current Debt came in at $450,000 for Q3 2021, unchanged from the prior quarter.

Analysis

Skye Bioscience (SKYE) Non-Current Debt (2013 - 2021) Analysis & Trends

Going back to Q2 2013, Skye Bioscience's Non-Current Debt data covers 5 quarters.

  • Business Quant data shows SKYE's Non-Current Debt at $450,000 (Q2 2021), $450,000 (Q1 2021) and $450,000 (Q4 2020) in the three quarters before Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn 62.48 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 60.50 Bn
10 Skye Bioscience 7.90 Mn -80.32 Mn - -107,288.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 450,000.00
Jun 30, 2021 450,000.00
Mar 31, 2021 463,177.00
Dec 31, 2020 450,000.00
Apr 30, 2013 15,851.00
API Access

Skye Bioscience Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=SKYE&period=max&api_key=YOUR_API_KEY